Study finds that a CDC-recommended hospital disinfectant is ineffective against Clostridioides difficile, a hospital-acquired infection affecting 500,000 Americans every year.
A retrospective cohort study of inpatient encounters from 3 hospitals in the Duke University Health System showed greater rates of testing among White patients compared to Black and NWNB patients.
The bacterium Clostridioides difficile (C. difficile) forms organelles that help them defend against iron in the colon. According to a group of scientists from Vanderbilt University, this pathogen, which causes serious gastrointestinal infections, expresses fez genes to build structures called ferrosomes that store excess iron that is toxic to it. Its ferrosomes are surrounded by membrane and could be a target against this microorganism.
Study finds that doxycycline, an antibiotic typically reserved as an alternative to azithromycin, is associated with reducing clostridioides difficile infections in pneumonia patients.